110 related articles for article (PubMed ID: 3971018)
1. Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N-(2-hydroxypropyl) methacrylamide copolymers.
Rejmanová P; Kopecek J; Duncan R; Lloyd JB
Biomaterials; 1985 Jan; 6(1):45-8. PubMed ID: 3971018
[TBL] [Abstract][Full Text] [Related]
2. Degradation of side-chains of N-(2-hydroxypropyl)methacrylamide copolymers by lysosomal thiol-proteinases.
Duncan R; Cable HC; Lloyd JB; Rejmanová P; Kopecek J
Biosci Rep; 1982 Dec; 2(12):1041-6. PubMed ID: 6762230
[TBL] [Abstract][Full Text] [Related]
3. High-molecular weight HPMA copolymer-adriamycin conjugates.
Dvorák M; Kopecková P; Kopecek J
J Control Release; 1999 Aug; 60(2-3):321-32. PubMed ID: 10425337
[TBL] [Abstract][Full Text] [Related]
4. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.
Duncan R; Kopecková-Rejmanová P; Strohalm J; Hume I; Cable HC; Pohl J; Lloyd JB; Kopecek J
Br J Cancer; 1987 Feb; 55(2):165-74. PubMed ID: 3468994
[TBL] [Abstract][Full Text] [Related]
5. Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues.
Duncan R; Kopecek J; Rejmanová P; Lloyd JB
Biochim Biophys Acta; 1983 Feb; 755(3):518-21. PubMed ID: 6824743
[TBL] [Abstract][Full Text] [Related]
6. Controlled biodegradability of polymers--a key to drug delivery systems.
Kopecek J
Biomaterials; 1984 Jan; 5(1):19-25. PubMed ID: 6375745
[TBL] [Abstract][Full Text] [Related]
7. Polymeric drug-carriers containing doxorubicin and melanocyte-stimulating hormone: in vitro and in vivo evaluation against murine melanoma.
O'Hare KB; Duncan R; Strohalm J; Ulbrich K; Kopeckova P
J Drug Target; 1993; 1(3):217-29. PubMed ID: 8069563
[TBL] [Abstract][Full Text] [Related]
8. Effect of the chemical structure of N-(2-hydroxypropyl)methacrylamide copolymers on their ability to induce antibody formation in inbred strains of mice.
Rihová B; Kopecek J; Ulbrich K; Pospisil M; Mancal P
Biomaterials; 1984 May; 5(3):143-8. PubMed ID: 6733215
[TBL] [Abstract][Full Text] [Related]
9. Release of macromolecules and daunomycin from hydrophilic gels containing enzymatically degradable bonds.
Subr V; Duncan R; Kopecek J
J Biomater Sci Polym Ed; 1990; 1(4):261-78. PubMed ID: 1703786
[TBL] [Abstract][Full Text] [Related]
10. Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates.
Kasuya Y; Lu ZR; Kopecková P; Tabibi SE; Kopecek J
Pharm Res; 2002 Feb; 19(2):115-23. PubMed ID: 11883637
[TBL] [Abstract][Full Text] [Related]
11. Pinocytic uptake and intracellular degradation of N-(2-hydroxypropyl)methacrylamide copolymers. A potential drug delivery system.
Duncan R; Rejmanova P; Kopecek J; Lloyd JB
Biochim Biophys Acta; 1981 Nov; 678(1):143-50. PubMed ID: 7306576
[TBL] [Abstract][Full Text] [Related]
12. A polymeric drug delivery system for the simultaneous delivery of drugs activatable by enzymes and/or light.
Krinick NL; Sun Y; Joyner D; Spikes JD; Straight RC; Kopecek J
J Biomater Sci Polym Ed; 1994; 5(4):303-24. PubMed ID: 8025029
[TBL] [Abstract][Full Text] [Related]
13. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.
Duncan R; Kopecková P; Strohalm J; Hume IC; Lloyd JB; Kopecek J
Br J Cancer; 1988 Feb; 57(2):147-56. PubMed ID: 3358905
[TBL] [Abstract][Full Text] [Related]
14. Enantioselective release of 5-fluorouracil from N-(2-hydroxypropyl)methacrylamide-based copolymers via lysosomal enzymes.
Putnam D; Kopecek J
Bioconjug Chem; 1995; 6(4):483-92. PubMed ID: 7578369
[TBL] [Abstract][Full Text] [Related]
15. Tyrosinamide residues enhance pinocytic capture of N-(2-hydroxypropyl)methacrylamide copolymers.
Duncan R; Cable HC; Rejmanová P; Kopecek J; Lloyd JB
Biochim Biophys Acta; 1984 May; 799(1):1-8. PubMed ID: 6722178
[TBL] [Abstract][Full Text] [Related]
16. Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats.
Duncan R; Seymour LC; Scarlett L; Lloyd JB; Rejmanová P; Kopecek J
Biochim Biophys Acta; 1986 Jan; 880(1):62-71. PubMed ID: 3942780
[TBL] [Abstract][Full Text] [Related]
17. Bioaffinity therapy with antibodies and drugs bound to soluble synthetic polymers.
Ríhová B; Kopecek J; Kopecková-Rejmanová P; Strohalm J; Plocová D; Semorádová H
J Chromatogr; 1986 Apr; 376():221-33. PubMed ID: 3519635
[TBL] [Abstract][Full Text] [Related]
18. N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice.
Seymour LW; Ulbrich K; Wedge SR; Hume IC; Strohalm J; Duncan R
Br J Cancer; 1991 Jun; 63(6):859-66. PubMed ID: 1648946
[TBL] [Abstract][Full Text] [Related]
19. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
[TBL] [Abstract][Full Text] [Related]
20. Galactosylated N-2-hydroxypropyl methacrylamide-b-N-3-guanidinopropyl methacrylamide block copolymers as hepatocyte-targeting gene carriers.
Qin Z; Liu W; Li L; Guo L; Yao C; Li X
Bioconjug Chem; 2011 Aug; 22(8):1503-12. PubMed ID: 21688826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
